- 1 Department of Pharmacy, National University of Singapore, Singapore, Singapore
- 2 Department of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
- 3 Department of Radiation Oncology, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
- 4 Department of Medical Oncology, Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
- 5 Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
- 6 Department of Oncology, All India Institute of Medical Sciences, New Delhi, India
- 7 National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia
- 8 Department of Digestive Diseases and Nutrition, Tata Memorial Hospital, Mumbai, India
- 9 Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
Recent observational studies showed that post-operative aspirin use reduces cancer relapse and death in the earliest stages of colorectal cancer. We sought to evaluate the cost-effectiveness of aspirin as an adjuvant therapy in Stage I and II colorectal cancer patients aged 65 years and older.
* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.